Skip to main content
SpringerLink
Log in

Impaired uptake of 5 hydroxytryptamine platelet in essential hypertension: Clinical relevance

  • Clinical Pharmacology
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

Serotonin (5-hydroxytryptamine; 5HT) kinetics and platelet activation by 5HT were studied in patients with essential hypertension (n=45), and in matched normotensive subjects (n=45). Platelet response to 5HT and plasma beta-thromboglobulin increased with age in men, both normotensives and hypertensives. Beta-thromboglobulin and 5-hydroxyindoleacetic acid (5HIAA) excretion were higher in hyypertensive men than in wpmen. In women, no changes in platelet activity or 5HIAA excretion were found. 5HT plasma concentrations increased with blood pressure. Platelet 5HT uptake (Vmax and KM) were the lowest in hypertensive men ≥ 60 years of age. This may indicate that 5HT uptake in vivo in normotensives is far below maximum (VNT≪Vmax), whereas in hypertensive men it may be close to maximum (VHT ∼ Vmax). This could reflect significantly higher 5HT plasma concentrations in vivo hypertensives than in normotensives. The reduced uptake (which was found only in hypertensive men) may indicate an insufficient compensation of the enhanced 5HT release from aggregating platelets in older men, in whom platelet activity is enhanced in vivo. It is concluded that the defect in platelet 5HT uptake in hypertensives—along with the enhanced platelet aggregation—may contribute to a critical increase in 5HT plasma concentrations locally. An increase in 5HT concentrations leads to biochemical changes (higher 5HIAA excretion) as well as to an enhanced stimulation by 5HT. This may be of clinical relevance especially in older men, in whom 5HT2-receptor mediated responses are enhanced.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fetkovska N, Amstein R, Ferracin F, Regenass M, Bühler FR, Pletscher A. 5HT-kinetics and sensitivity of human blood platelets: Variations with age, gender and platelet number. Thromb Haemost 1988;60:486–490.

    Google Scholar 

  2. Gleerup G, Winther K. The effect of aging on human platelet sensitivity to serotonin. Eur J Clin Invest 1988;18:469–471.

    Google Scholar 

  3. Bhargava KP, Raina N, Misra N, Shanker K, Vrat S. Uptake of serotonin by human platelets and its relevance to CNS involvement in hypertension. Life Sci 1979;25:195–200.

    Google Scholar 

  4. Kamal LA, Le Quan-Bui KH, Meyer P. Decreased uptake of 3H-serotonin and endogenous content of serotonin in blood platelets in hypertensive patients. Hypertension 1984;6:566–573.

    Google Scholar 

  5. Guicheney P, Baudoin-Legros M, Valtier D, Meyer P. Reduced serotonin content and uptake in platelets from patients with essential hypertension: Is a ouabain-like factor involved? Thromb Res 1987;45:289–297.

    Google Scholar 

  6. Guicheney P, Devynck MA, Cloix JR, Pernollet MG, Grichois ML, Meyer P. Platelet 5HT content and uptake in essential hypertension: Role of endogenous digitalis-like factors and plasma cholesterol. J Hypertens 1988;6:873–879.

    Google Scholar 

  7. Fetkovska N, Amstein R, Ferracin F, Regenass M, Bühler FR, Pletscher A. 5-HT hydroxtryptamine kinetics and activation of blood platelets in patients with essential hypertension. Hypertension 1989, in press.

  8. Born GVR, Cross MJ. The aggregation of blood platelets. J Physiol 1963;168:178–195.

    Google Scholar 

  9. Ludlam CA, Moore S, Bolton AE, Pepper DS, Cash JD. The release of a human platelet specific protein measured by a radioimmunoassay. Thromb Res 1975;6:543–548.

    Google Scholar 

  10. Kaplan KL, Owen J. Plasma levels of β-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 1981;52:199–202.

    Google Scholar 

  11. Honegger CG, Burri R, Langemann H, Kempf A. Determination of neurotransmitter system in human cerebrospinal fluid and rat nervous tissue by high performance liquid chromatrography with on-line data evaluation. J Chromatogr 1984;309:53–61.

    Google Scholar 

  12. Buszewski B, Sebekova K, Bozek P, Stibranyi L, Jendrichovsky J, Novak I, Berek D. Evaluation of various bonded-phase materials for the off-line clean-up procedurof urinary 5-hydroxyindoleacetic acid prior to its determination by HPLC. Chromatrographia 1986;22:299–302.

    Google Scholar 

  13. Koch DD, Kissinger PI. Determination of tryptophan and several of its metabolites in physiological samples by reversed-phase liquid chromatography with electrochemical detection. J Chromatogr 1979;164:441–445.

    Google Scholar 

  14. Johnson M, Ramey E, Ramwell PW. Sex and age differences in human platelet aggregation. Nature 1975;253:355–357.

    Google Scholar 

  15. Yokouama M, Kusui A, Sakamoto S, Fukuzaki H. Age-associated increments in human platelet alpha adrenoceptor capacity. Possible mechanism for platelet hyperactivity to epinephrine in aging man. Thromb Res 1984;34:287–290.

    Google Scholar 

  16. Yamanishi J, Sano H, Saito K, Furuta Y, Fukuzaki H. Plasma concentrations of platelet-specific proteins in different stages of essential hypertension: Interactions between platelet aggregation, blood lipids and age. Thromb Haemost 1985;54:539–543.

    Google Scholar 

  17. Meade TW, Vickers MV, Thompson SG, Stirling Y, Haines AP, Miller CJ. Epidemiological characteristics of platelet aggregability. Br J Med 1985;290:428–431.

    Google Scholar 

  18. Brodde OE, Anlauf M, Graben N, Bock KD. Age dependent decrease of alpha2-adrenergic receptor number in human platelets. Eur J Pharmacol 1982;81:345–347.

    Google Scholar 

  19. Winther K, Naesh O. Aging and platelet beta-adrenoceptor function. Eur J Pharmacol 1987;136:219–221.

    Google Scholar 

  20. De Clerck F, Davids JL, Janssen PAJ. Inhibition of 5-hydroxytryptamine-induced and amplified human platelet aggregation by ketanserin (R 41468), a selective 5HT2-receptor antagonist. Agents and Actions 1982;12:388–397.

    Google Scholar 

  21. Coccheri S, Fiorentini. Platelet adhesiveness and aggregation in hypertensive patients. Acta Med Scand 1971;525:273–275.

    Google Scholar 

  22. Vlachakis ND, Aldort FL. Platelet aggregation in relation to plasma catecholamines in patients with hypertension. Atherosclerosis 1979;32:451–460.

    Google Scholar 

  23. Mehta J, Mehta P. Platelet function in hypertension and effects of therapy. Am J Cardiol 1981;47:331–334.

    Google Scholar 

  24. Fetkovska N, Amstein R, Ferracin F, Bühler FR, Pletscher A. Low-density lipoprotein enhances platelet activation in parallel with the height of blood pressure. J Hypertens 1988;6(Suppl 4):S646-S648.

    Google Scholar 

  25. Ikeda T, Nonaka Y, Goto A, Ishii M. Effects of prazosin on platelet aggregation and plasma beta-thromboglobulin in essential hypertension. Clin Pharmacol Ther 1985;37:601–605.

    Google Scholar 

  26. Lande K, Os I, Kjeldsen SE, Westheim A, Hjesmann I, Eide I, Gjesdal K. Blood platelet size, platelet release reaction and response to infused adrenaline are increased in essential hypertension. J Hypertens 1986;4(Suppl 6):S234-S236.

    Google Scholar 

  27. Kjeldsen SE, Lande K, Gjesdal K, Westheim A, Foss OP, Leren P, Edie IK. Increased platelet release reaction in 50-year-old men with essential hypertension: Correlation with atherogenetic cholesterol fractions. Am Heart J 1987;113:151–155.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinic of Pharmacotherapy, Medical Bionics Research Institute, Bratislava, Czechoslovakia

    Natalia Fetkovska

  2. Department of Research, University Hospital, Basel, Switzerland

    Alfred Pletscher, Fabrizia Ferracin, Ruth Amstein & Fritz R. Buhler

Authors
  1. Natalia Fetkovska
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alfred Pletscher
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fabrizia Ferracin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ruth Amstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fritz R. Buhler
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fetkovska, N., Pletscher, A., Ferracin, F. et al. Impaired uptake of 5 hydroxytryptamine platelet in essential hypertension: Clinical relevance. Cardiovasc Drug Ther 4, 105–109 (1990). https://doi.org/10.1007/BF00053439

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00053439

Key words

Search

Navigation